nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFA13—thyroid cancer	0.467	1	CbGaD
Metformin—NDUFS2—Doxorubicin—thyroid cancer	0.101	0.333	CbGbCtD
Metformin—NDUFS3—Doxorubicin—thyroid cancer	0.101	0.333	CbGbCtD
Metformin—NDUFS7—Doxorubicin—thyroid cancer	0.101	0.333	CbGbCtD
Metformin—NDUFA13—neck—thyroid cancer	0.000941	0.0118	CbGeAlD
Metformin—NDUFS6—Afatinib—Vandetanib—thyroid cancer	0.000937	0.362	CbGdCrCtD
Metformin—NDUFAB1—Afatinib—Vandetanib—thyroid cancer	0.000857	0.331	CbGdCrCtD
Metformin—ND2—neck—thyroid cancer	0.000822	0.0103	CbGeAlD
Metformin—ND4L—neck—thyroid cancer	0.000822	0.0103	CbGeAlD
Metformin—ND5—neck—thyroid cancer	0.000822	0.0103	CbGeAlD
Metformin—ND3—neck—thyroid cancer	0.000822	0.0103	CbGeAlD
Metformin—NDUFA13—Afatinib—Vandetanib—thyroid cancer	0.000797	0.308	CbGdCrCtD
Metformin—ND4—neck—thyroid cancer	0.000796	0.00998	CbGeAlD
Metformin—NDUFB2—neck—thyroid cancer	0.000731	0.00916	CbGeAlD
Metformin—ND6—neck—thyroid cancer	0.000719	0.00901	CbGeAlD
Metformin—NDUFA5—neck—thyroid cancer	0.000696	0.00873	CbGeAlD
Metformin—NDUFS4—neck—thyroid cancer	0.000658	0.00826	CbGeAlD
Metformin—NDUFB4—neck—thyroid cancer	0.00065	0.00815	CbGeAlD
Metformin—ND3—saliva-secreting gland—thyroid cancer	0.000641	0.00804	CbGeAlD
Metformin—ND2—saliva-secreting gland—thyroid cancer	0.000641	0.00804	CbGeAlD
Metformin—ND5—saliva-secreting gland—thyroid cancer	0.000641	0.00804	CbGeAlD
Metformin—ND4L—saliva-secreting gland—thyroid cancer	0.000641	0.00804	CbGeAlD
Metformin—NDUFA4—neck—thyroid cancer	0.000638	0.008	CbGeAlD
Metformin—NDUFV1—neck—thyroid cancer	0.000634	0.00795	CbGeAlD
Metformin—NDUFS5—neck—thyroid cancer	0.00063	0.00791	CbGeAlD
Metformin—ND4—saliva-secreting gland—thyroid cancer	0.000621	0.00778	CbGeAlD
Metformin—NDUFC1—saliva-secreting gland—thyroid cancer	0.000575	0.00721	CbGeAlD
Metformin—ND6—saliva-secreting gland—thyroid cancer	0.000561	0.00703	CbGeAlD
Metformin—NDUFB3—saliva-secreting gland—thyroid cancer	0.000556	0.00697	CbGeAlD
Metformin—NDUFAF2—saliva-secreting gland—thyroid cancer	0.000556	0.00697	CbGeAlD
Metformin—NDUFA11—saliva-secreting gland—thyroid cancer	0.000543	0.00681	CbGeAlD
Metformin—NDUFA5—saliva-secreting gland—thyroid cancer	0.000543	0.00681	CbGeAlD
Metformin—NDUFAF4—saliva-secreting gland—thyroid cancer	0.000539	0.00676	CbGeAlD
Metformin—NDUFB6—saliva-secreting gland—thyroid cancer	0.000539	0.00676	CbGeAlD
Metformin—NDUFA7—thyroid gland—thyroid cancer	0.000535	0.00671	CbGeAlD
Metformin—NDUFB10—saliva-secreting gland—thyroid cancer	0.000531	0.00666	CbGeAlD
Metformin—NDUFA12—saliva-secreting gland—thyroid cancer	0.000528	0.00662	CbGeAlD
Metformin—NDUFB7—saliva-secreting gland—thyroid cancer	0.000528	0.00662	CbGeAlD
Metformin—NDUFA4L2—trachea—thyroid cancer	0.000526	0.0066	CbGeAlD
Metformin—NDUFB1—saliva-secreting gland—thyroid cancer	0.000524	0.00657	CbGeAlD
Metformin—NDUFS8—saliva-secreting gland—thyroid cancer	0.000524	0.00657	CbGeAlD
Metformin—NDUFB5—saliva-secreting gland—thyroid cancer	0.000517	0.00648	CbGeAlD
Metformin—NDUFA6—saliva-secreting gland—thyroid cancer	0.000517	0.00648	CbGeAlD
Metformin—NDUFS4—saliva-secreting gland—thyroid cancer	0.000514	0.00644	CbGeAlD
Metformin—SLC29A4—thyroid gland—thyroid cancer	0.000511	0.0064	CbGeAlD
Metformin—NDUFC2—neck—thyroid cancer	0.000509	0.00639	CbGeAlD
Metformin—NDUFB4—saliva-secreting gland—thyroid cancer	0.000507	0.00636	CbGeAlD
Metformin—NDUFAB1—saliva-secreting gland—thyroid cancer	0.000504	0.00632	CbGeAlD
Metformin—NDUFV3—head—thyroid cancer	0.000501	0.00628	CbGeAlD
Metformin—NDUFB9—saliva-secreting gland—thyroid cancer	0.000501	0.00628	CbGeAlD
Metformin—NDUFA8—saliva-secreting gland—thyroid cancer	0.000501	0.00628	CbGeAlD
Metformin—NDUFA4—saliva-secreting gland—thyroid cancer	0.000498	0.00624	CbGeAlD
Metformin—NDUFB11—saliva-secreting gland—thyroid cancer	0.000495	0.0062	CbGeAlD
Metformin—NDUFV1—saliva-secreting gland—thyroid cancer	0.000495	0.0062	CbGeAlD
Metformin—NDUFS5—saliva-secreting gland—thyroid cancer	0.000492	0.00617	CbGeAlD
Metformin—NDUFB8—saliva-secreting gland—thyroid cancer	0.000492	0.00617	CbGeAlD
Metformin—NDUFS6—head—thyroid cancer	0.000487	0.00611	CbGeAlD
Metformin—SLC29A4—head—thyroid cancer	0.000453	0.00568	CbGeAlD
Metformin—NDUFA13—thyroid gland—thyroid cancer	0.000448	0.00562	CbGeAlD
Metformin—NDUFAF3—head—thyroid cancer	0.000443	0.00556	CbGeAlD
Metformin—NDUFAF1—trachea—thyroid cancer	0.000436	0.00547	CbGeAlD
Metformin—NDUFAF2—trachea—thyroid cancer	0.000429	0.00538	CbGeAlD
Metformin—NDUFB3—trachea—thyroid cancer	0.000429	0.00538	CbGeAlD
Metformin—NDUFV2—thyroid gland—thyroid cancer	0.000428	0.00537	CbGeAlD
Metformin—NDUFA11—trachea—thyroid cancer	0.000419	0.00526	CbGeAlD
Metformin—NDUFA5—trachea—thyroid cancer	0.000419	0.00526	CbGeAlD
Metformin—NDUFA4L2—thyroid gland—thyroid cancer	0.000416	0.00522	CbGeAlD
Metformin—NDUFAF4—trachea—thyroid cancer	0.000416	0.00522	CbGeAlD
Metformin—NDUFB6—trachea—thyroid cancer	0.000416	0.00522	CbGeAlD
Metformin—NDUFB10—trachea—thyroid cancer	0.00041	0.00514	CbGeAlD
Metformin—NDUFA12—trachea—thyroid cancer	0.000407	0.0051	CbGeAlD
Metformin—NDUFB7—trachea—thyroid cancer	0.000407	0.0051	CbGeAlD
Metformin—NDUFS8—trachea—thyroid cancer	0.000404	0.00507	CbGeAlD
Metformin—ND1—neck—thyroid cancer	0.000402	0.00504	CbGeAlD
Metformin—NDUFB5—trachea—thyroid cancer	0.000399	0.005	CbGeAlD
Metformin—NDUFA6—trachea—thyroid cancer	0.000399	0.005	CbGeAlD
Metformin—NDUFA9—head—thyroid cancer	0.000397	0.00498	CbGeAlD
Metformin—NDUFA13—head—thyroid cancer	0.000397	0.00498	CbGeAlD
Metformin—NDUFC2—saliva-secreting gland—thyroid cancer	0.000397	0.00498	CbGeAlD
Metformin—NDUFS4—trachea—thyroid cancer	0.000396	0.00497	CbGeAlD
Metformin—ND4L—thyroid gland—thyroid cancer	0.000391	0.00491	CbGeAlD
Metformin—ND3—thyroid gland—thyroid cancer	0.000391	0.00491	CbGeAlD
Metformin—ND2—thyroid gland—thyroid cancer	0.000391	0.00491	CbGeAlD
Metformin—ND5—thyroid gland—thyroid cancer	0.000391	0.00491	CbGeAlD
Metformin—NDUFB4—trachea—thyroid cancer	0.000391	0.0049	CbGeAlD
Metformin—NDUFA1—head—thyroid cancer	0.000391	0.0049	CbGeAlD
Metformin—NDUFAB1—trachea—thyroid cancer	0.000389	0.00487	CbGeAlD
Metformin—NDUFB9—trachea—thyroid cancer	0.000386	0.00484	CbGeAlD
Metformin—NDUFA8—trachea—thyroid cancer	0.000386	0.00484	CbGeAlD
Metformin—NDUFA4—trachea—thyroid cancer	0.000384	0.00481	CbGeAlD
Metformin—NDUFS2—saliva-secreting gland—thyroid cancer	0.000382	0.00479	CbGeAlD
Metformin—NDUFB11—trachea—thyroid cancer	0.000382	0.00479	CbGeAlD
Metformin—NDUFV1—trachea—thyroid cancer	0.000382	0.00479	CbGeAlD
Metformin—NDUFV2—head—thyroid cancer	0.00038	0.00476	CbGeAlD
Metformin—NDUFS5—trachea—thyroid cancer	0.000379	0.00476	CbGeAlD
Metformin—NDUFB8—trachea—thyroid cancer	0.000379	0.00476	CbGeAlD
Metformin—ND4—thyroid gland—thyroid cancer	0.000379	0.00475	CbGeAlD
Metformin—NDUFS3—saliva-secreting gland—thyroid cancer	0.000377	0.00473	CbGeAlD
Metformin—NDUFA2—thyroid gland—thyroid cancer	0.000371	0.00465	CbGeAlD
Metformin—NDUFA10—thyroid gland—thyroid cancer	0.000354	0.00444	CbGeAlD
Metformin—NDUFC1—thyroid gland—thyroid cancer	0.000351	0.0044	CbGeAlD
Metformin—NDUFB2—thyroid gland—thyroid cancer	0.000348	0.00436	CbGeAlD
Metformin—ND2—head—thyroid cancer	0.000347	0.00435	CbGeAlD
Metformin—ND5—head—thyroid cancer	0.000347	0.00435	CbGeAlD
Metformin—ND4L—head—thyroid cancer	0.000347	0.00435	CbGeAlD
Metformin—ND3—head—thyroid cancer	0.000347	0.00435	CbGeAlD
Metformin—NDUFAF1—thyroid gland—thyroid cancer	0.000345	0.00433	CbGeAlD
Metformin—ND6—thyroid gland—thyroid cancer	0.000342	0.00429	CbGeAlD
Metformin—NDUFB3—thyroid gland—thyroid cancer	0.000339	0.00426	CbGeAlD
Metformin—NDUFAF2—thyroid gland—thyroid cancer	0.000339	0.00426	CbGeAlD
Metformin—ND4—head—thyroid cancer	0.000336	0.00421	CbGeAlD
Metformin—NDUFA7—lymph node—thyroid cancer	0.000332	0.00417	CbGeAlD
Metformin—NDUFA11—thyroid gland—thyroid cancer	0.000331	0.00416	CbGeAlD
Metformin—NDUFA5—thyroid gland—thyroid cancer	0.000331	0.00416	CbGeAlD
Metformin—NDUFAF4—thyroid gland—thyroid cancer	0.000329	0.00413	CbGeAlD
Metformin—NDUFB6—thyroid gland—thyroid cancer	0.000329	0.00413	CbGeAlD
Metformin—NDUFS1—thyroid gland—thyroid cancer	0.000327	0.0041	CbGeAlD
Metformin—PRKAB1—trachea—thyroid cancer	0.000325	0.00408	CbGeAlD
Metformin—NDUFB10—thyroid gland—thyroid cancer	0.000324	0.00407	CbGeAlD
Metformin—NDUFA12—thyroid gland—thyroid cancer	0.000322	0.00404	CbGeAlD
Metformin—NDUFB7—thyroid gland—thyroid cancer	0.000322	0.00404	CbGeAlD
Metformin—NDUFB1—thyroid gland—thyroid cancer	0.00032	0.00401	CbGeAlD
Metformin—NDUFS8—thyroid gland—thyroid cancer	0.00032	0.00401	CbGeAlD
Metformin—NDUFB5—thyroid gland—thyroid cancer	0.000315	0.00396	CbGeAlD
Metformin—NDUFA6—thyroid gland—thyroid cancer	0.000315	0.00396	CbGeAlD
Metformin—NDUFA10—head—thyroid cancer	0.000314	0.00394	CbGeAlD
Metformin—NDUFS4—thyroid gland—thyroid cancer	0.000313	0.00393	CbGeAlD
Metformin—ND1—saliva-secreting gland—thyroid cancer	0.000313	0.00393	CbGeAlD
Metformin—NDUFC1—head—thyroid cancer	0.000311	0.0039	CbGeAlD
Metformin—NDUFB4—thyroid gland—thyroid cancer	0.000309	0.00388	CbGeAlD
Metformin—NDUFB2—head—thyroid cancer	0.000309	0.00387	CbGeAlD
Metformin—NDUFAB1—thyroid gland—thyroid cancer	0.000307	0.00386	CbGeAlD
Metformin—NDUFC2—trachea—thyroid cancer	0.000306	0.00384	CbGeAlD
Metformin—NDUFAF1—head—thyroid cancer	0.000306	0.00384	CbGeAlD
Metformin—NDUFB9—thyroid gland—thyroid cancer	0.000306	0.00383	CbGeAlD
Metformin—NDUFA8—thyroid gland—thyroid cancer	0.000306	0.00383	CbGeAlD
Metformin—NDUFA4—thyroid gland—thyroid cancer	0.000304	0.00381	CbGeAlD
Metformin—ND6—head—thyroid cancer	0.000303	0.00381	CbGeAlD
Metformin—NDUFB11—thyroid gland—thyroid cancer	0.000302	0.00379	CbGeAlD
Metformin—NDUFV1—thyroid gland—thyroid cancer	0.000302	0.00379	CbGeAlD
Metformin—NDUFAF2—head—thyroid cancer	0.000301	0.00378	CbGeAlD
Metformin—NDUFS5—thyroid gland—thyroid cancer	0.0003	0.00376	CbGeAlD
Metformin—NDUFB8—thyroid gland—thyroid cancer	0.0003	0.00376	CbGeAlD
Metformin—NDUFS2—trachea—thyroid cancer	0.000294	0.00369	CbGeAlD
Metformin—NDUFA11—head—thyroid cancer	0.000294	0.00369	CbGeAlD
Metformin—NDUFA5—head—thyroid cancer	0.000294	0.00369	CbGeAlD
Metformin—NDUFB6—head—thyroid cancer	0.000292	0.00366	CbGeAlD
Metformin—NDUFAF4—head—thyroid cancer	0.000292	0.00366	CbGeAlD
Metformin—Vision blurred—Vandetanib—thyroid cancer	0.000291	0.00614	CcSEcCtD
Metformin—Hypothermia—Doxorubicin—thyroid cancer	0.000291	0.00614	CcSEcCtD
Metformin—Body temperature decreased—Doxorubicin—thyroid cancer	0.000291	0.00614	CcSEcCtD
Metformin—NDUFS3—trachea—thyroid cancer	0.000291	0.00365	CbGeAlD
Metformin—NDUFS1—head—thyroid cancer	0.00029	0.00363	CbGeAlD
Metformin—Tremor—Vandetanib—thyroid cancer	0.00029	0.00611	CcSEcCtD
Metformin—NDUFB10—head—thyroid cancer	0.000288	0.00361	CbGeAlD
Metformin—Abdominal discomfort—Sorafenib—thyroid cancer	0.000287	0.00605	CcSEcCtD
Metformin—NDUFB7—head—thyroid cancer	0.000286	0.00358	CbGeAlD
Metformin—NDUFA12—head—thyroid cancer	0.000286	0.00358	CbGeAlD
Metformin—NDUFS8—head—thyroid cancer	0.000284	0.00356	CbGeAlD
Metformin—NDUFB1—head—thyroid cancer	0.000284	0.00356	CbGeAlD
Metformin—NDUFS7—thyroid gland—thyroid cancer	0.000281	0.00353	CbGeAlD
Metformin—NDUFA6—head—thyroid cancer	0.00028	0.00351	CbGeAlD
Metformin—NDUFB5—head—thyroid cancer	0.00028	0.00351	CbGeAlD
Metformin—Neutropenia—Sorafenib—thyroid cancer	0.00028	0.0059	CcSEcCtD
Metformin—NDUFS4—head—thyroid cancer	0.000278	0.00349	CbGeAlD
Metformin—NDUFB4—head—thyroid cancer	0.000274	0.00344	CbGeAlD
Metformin—NDUFAB1—head—thyroid cancer	0.000273	0.00342	CbGeAlD
Metformin—Nail disorder—Epirubicin—thyroid cancer	0.000272	0.00573	CcSEcCtD
Metformin—Loss of consciousness—Vandetanib—thyroid cancer	0.000272	0.00573	CcSEcCtD
Metformin—NDUFA8—head—thyroid cancer	0.000271	0.0034	CbGeAlD
Metformin—NDUFB9—head—thyroid cancer	0.000271	0.0034	CbGeAlD
Metformin—NDUFA4—head—thyroid cancer	0.000269	0.00338	CbGeAlD
Metformin—NDUFB11—head—thyroid cancer	0.000268	0.00336	CbGeAlD
Metformin—NDUFV1—head—thyroid cancer	0.000268	0.00336	CbGeAlD
Metformin—Hypertension—Vandetanib—thyroid cancer	0.000267	0.00563	CcSEcCtD
Metformin—Infestation—Sorafenib—thyroid cancer	0.000267	0.00563	CcSEcCtD
Metformin—Infestation NOS—Sorafenib—thyroid cancer	0.000267	0.00563	CcSEcCtD
Metformin—NDUFS5—head—thyroid cancer	0.000266	0.00334	CbGeAlD
Metformin—NDUFB8—head—thyroid cancer	0.000266	0.00334	CbGeAlD
Metformin—NDUFV2—lymph node—thyroid cancer	0.000266	0.00333	CbGeAlD
Metformin—Chest pain—Vandetanib—thyroid cancer	0.000263	0.00555	CcSEcCtD
Metformin—Neuropathy peripheral—Sorafenib—thyroid cancer	0.000262	0.00552	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.000261	0.00551	CcSEcCtD
Metformin—NDUFA4L2—lymph node—thyroid cancer	0.000259	0.00324	CbGeAlD
Metformin—PRKAB1—thyroid gland—thyroid cancer	0.000257	0.00323	CbGeAlD
Metformin—Hepatobiliary disease—Sorafenib—thyroid cancer	0.000252	0.00532	CcSEcCtD
Metformin—Oedema—Vandetanib—thyroid cancer	0.000252	0.00532	CcSEcCtD
Metformin—Nail disorder—Doxorubicin—thyroid cancer	0.000251	0.0053	CcSEcCtD
Metformin—Infection—Vandetanib—thyroid cancer	0.000251	0.00529	CcSEcCtD
Metformin—NDUFS7—head—thyroid cancer	0.000249	0.00313	CbGeAlD
Metformin—Nervous system disorder—Vandetanib—thyroid cancer	0.000247	0.00522	CcSEcCtD
Metformin—Thrombocytopenia—Vandetanib—thyroid cancer	0.000247	0.00521	CcSEcCtD
Metformin—Skin disorder—Vandetanib—thyroid cancer	0.000245	0.00517	CcSEcCtD
Metformin—ND4L—lymph node—thyroid cancer	0.000243	0.00305	CbGeAlD
Metformin—ND5—lymph node—thyroid cancer	0.000243	0.00305	CbGeAlD
Metformin—ND2—lymph node—thyroid cancer	0.000243	0.00305	CbGeAlD
Metformin—ND3—lymph node—thyroid cancer	0.000243	0.00305	CbGeAlD
Metformin—NDUFC2—thyroid gland—thyroid cancer	0.000242	0.00304	CbGeAlD
Metformin—Connective tissue disorder—Sorafenib—thyroid cancer	0.000235	0.00496	CcSEcCtD
Metformin—ND4—lymph node—thyroid cancer	0.000235	0.00295	CbGeAlD
Metformin—NDUFS2—thyroid gland—thyroid cancer	0.000233	0.00292	CbGeAlD
Metformin—NDUFA2—lymph node—thyroid cancer	0.00023	0.00289	CbGeAlD
Metformin—NDUFS3—thyroid gland—thyroid cancer	0.00023	0.00289	CbGeAlD
Metformin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00023	0.00485	CcSEcCtD
Metformin—Fungal infection—Epirubicin—thyroid cancer	0.000228	0.00482	CcSEcCtD
Metformin—PRKAB1—head—thyroid cancer	0.000228	0.00286	CbGeAlD
Metformin—Paraesthesia—Vandetanib—thyroid cancer	0.000227	0.00478	CcSEcCtD
Metformin—Dyspnoea—Vandetanib—thyroid cancer	0.000225	0.00474	CcSEcCtD
Metformin—Cardiac disorder—Sorafenib—thyroid cancer	0.000222	0.00469	CcSEcCtD
Metformin—Flushing—Sorafenib—thyroid cancer	0.000222	0.00469	CcSEcCtD
Metformin—Dyspepsia—Vandetanib—thyroid cancer	0.000222	0.00468	CcSEcCtD
Metformin—NDUFA10—lymph node—thyroid cancer	0.00022	0.00276	CbGeAlD
Metformin—Decreased appetite—Vandetanib—thyroid cancer	0.000219	0.00463	CcSEcCtD
Metformin—NDUFC1—lymph node—thyroid cancer	0.000218	0.00273	CbGeAlD
Metformin—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000218	0.00459	CcSEcCtD
Metformin—Fatigue—Vandetanib—thyroid cancer	0.000217	0.00459	CcSEcCtD
Metformin—Angiopathy—Sorafenib—thyroid cancer	0.000217	0.00458	CcSEcCtD
Metformin—Immune system disorder—Sorafenib—thyroid cancer	0.000216	0.00456	CcSEcCtD
Metformin—NDUFB2—lymph node—thyroid cancer	0.000216	0.00271	CbGeAlD
Metformin—Rigors—Epirubicin—thyroid cancer	0.000216	0.00455	CcSEcCtD
Metformin—Mediastinal disorder—Sorafenib—thyroid cancer	0.000216	0.00455	CcSEcCtD
Metformin—Constipation—Vandetanib—thyroid cancer	0.000216	0.00455	CcSEcCtD
Metformin—NDUFC2—head—thyroid cancer	0.000215	0.0027	CbGeAlD
Metformin—NDUFAF1—lymph node—thyroid cancer	0.000214	0.00269	CbGeAlD
Metformin—ND6—lymph node—thyroid cancer	0.000212	0.00267	CbGeAlD
Metformin—Fungal infection—Doxorubicin—thyroid cancer	0.000211	0.00446	CcSEcCtD
Metformin—Blood disorder—Epirubicin—thyroid cancer	0.000211	0.00445	CcSEcCtD
Metformin—NDUFB3—lymph node—thyroid cancer	0.000211	0.00264	CbGeAlD
Metformin—NDUFAF2—lymph node—thyroid cancer	0.000211	0.00264	CbGeAlD
Metformin—Erythema—Sorafenib—thyroid cancer	0.000209	0.0044	CcSEcCtD
Metformin—Malnutrition—Sorafenib—thyroid cancer	0.000209	0.0044	CcSEcCtD
Metformin—NDUFS2—head—thyroid cancer	0.000207	0.00259	CbGeAlD
Metformin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000206	0.00435	CcSEcCtD
Metformin—NDUFA11—lymph node—thyroid cancer	0.000206	0.00258	CbGeAlD
Metformin—NDUFA5—lymph node—thyroid cancer	0.000206	0.00258	CbGeAlD
Metformin—NDUFB6—lymph node—thyroid cancer	0.000204	0.00256	CbGeAlD
Metformin—NDUFAF4—lymph node—thyroid cancer	0.000204	0.00256	CbGeAlD
Metformin—Dysgeusia—Sorafenib—thyroid cancer	0.000204	0.00431	CcSEcCtD
Metformin—NDUFS3—head—thyroid cancer	0.000204	0.00256	CbGeAlD
Metformin—NDUFS1—lymph node—thyroid cancer	0.000203	0.00254	CbGeAlD
Metformin—NDUFB10—lymph node—thyroid cancer	0.000201	0.00253	CbGeAlD
Metformin—Muscle spasms—Sorafenib—thyroid cancer	0.0002	0.00423	CcSEcCtD
Metformin—NDUFB7—lymph node—thyroid cancer	0.0002	0.00251	CbGeAlD
Metformin—NDUFA12—lymph node—thyroid cancer	0.0002	0.00251	CbGeAlD
Metformin—Rigors—Doxorubicin—thyroid cancer	0.0002	0.00421	CcSEcCtD
Metformin—Abdominal pain—Vandetanib—thyroid cancer	0.000199	0.00421	CcSEcCtD
Metformin—NDUFS8—lymph node—thyroid cancer	0.000199	0.00249	CbGeAlD
Metformin—NDUFB1—lymph node—thyroid cancer	0.000199	0.00249	CbGeAlD
Metformin—NDUFA6—lymph node—thyroid cancer	0.000196	0.00246	CbGeAlD
Metformin—NDUFB5—lymph node—thyroid cancer	0.000196	0.00246	CbGeAlD
Metformin—Blood disorder—Doxorubicin—thyroid cancer	0.000195	0.00412	CcSEcCtD
Metformin—NDUFS4—lymph node—thyroid cancer	0.000195	0.00244	CbGeAlD
Metformin—NDUFB4—lymph node—thyroid cancer	0.000192	0.00241	CbGeAlD
Metformin—ND1—thyroid gland—thyroid cancer	0.000191	0.0024	CbGeAlD
Metformin—NDUFAB1—lymph node—thyroid cancer	0.000191	0.0024	CbGeAlD
Metformin—NDUFA8—lymph node—thyroid cancer	0.00019	0.00238	CbGeAlD
Metformin—NDUFB9—lymph node—thyroid cancer	0.00019	0.00238	CbGeAlD
Metformin—NDUFA4—lymph node—thyroid cancer	0.000189	0.00237	CbGeAlD
Metformin—NDUFV1—lymph node—thyroid cancer	0.000187	0.00235	CbGeAlD
Metformin—NDUFB11—lymph node—thyroid cancer	0.000187	0.00235	CbGeAlD
Metformin—Syncope—Sorafenib—thyroid cancer	0.000187	0.00394	CcSEcCtD
Metformin—NDUFB8—lymph node—thyroid cancer	0.000186	0.00234	CbGeAlD
Metformin—NDUFS5—lymph node—thyroid cancer	0.000186	0.00234	CbGeAlD
Metformin—Loss of consciousness—Sorafenib—thyroid cancer	0.000183	0.00387	CcSEcCtD
Metformin—Asthenia—Vandetanib—thyroid cancer	0.000181	0.00382	CcSEcCtD
Metformin—Hypertension—Sorafenib—thyroid cancer	0.00018	0.0038	CcSEcCtD
Metformin—Pruritus—Vandetanib—thyroid cancer	0.000178	0.00376	CcSEcCtD
Metformin—Myalgia—Sorafenib—thyroid cancer	0.000178	0.00374	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000176	0.00372	CcSEcCtD
Metformin—NDUFS7—lymph node—thyroid cancer	0.000175	0.00219	CbGeAlD
Metformin—Diarrhoea—Vandetanib—thyroid cancer	0.000173	0.00364	CcSEcCtD
Metformin—SLC22A3—saliva-secreting gland—thyroid cancer	0.00017	0.00213	CbGeAlD
Metformin—ND1—head—thyroid cancer	0.00017	0.00213	CbGeAlD
Metformin—Infection—Sorafenib—thyroid cancer	0.000169	0.00357	CcSEcCtD
Metformin—Shock—Sorafenib—thyroid cancer	0.000167	0.00353	CcSEcCtD
Metformin—Nervous system disorder—Sorafenib—thyroid cancer	0.000167	0.00352	CcSEcCtD
Metformin—Dizziness—Vandetanib—thyroid cancer	0.000167	0.00352	CcSEcCtD
Metformin—Thrombocytopenia—Sorafenib—thyroid cancer	0.000167	0.00351	CcSEcCtD
Metformin—Neuropathy—Epirubicin—thyroid cancer	0.000166	0.00349	CcSEcCtD
Metformin—Skin disorder—Sorafenib—thyroid cancer	0.000165	0.00349	CcSEcCtD
Metformin—Anorexia—Sorafenib—thyroid cancer	0.000162	0.00342	CcSEcCtD
Metformin—Vomiting—Vandetanib—thyroid cancer	0.00016	0.00338	CcSEcCtD
Metformin—PRKAB1—lymph node—thyroid cancer	0.00016	0.002	CbGeAlD
Metformin—Rash—Vandetanib—thyroid cancer	0.000159	0.00335	CcSEcCtD
Metformin—Dermatitis—Vandetanib—thyroid cancer	0.000159	0.00335	CcSEcCtD
Metformin—Headache—Vandetanib—thyroid cancer	0.000158	0.00333	CcSEcCtD
Metformin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000155	0.00327	CcSEcCtD
Metformin—Neuropathy—Doxorubicin—thyroid cancer	0.000153	0.00323	CcSEcCtD
Metformin—Dyspnoea—Sorafenib—thyroid cancer	0.000152	0.0032	CcSEcCtD
Metformin—NDUFC2—lymph node—thyroid cancer	0.000151	0.00189	CbGeAlD
Metformin—Nausea—Vandetanib—thyroid cancer	0.00015	0.00316	CcSEcCtD
Metformin—Dyspepsia—Sorafenib—thyroid cancer	0.00015	0.00316	CcSEcCtD
Metformin—Decreased appetite—Sorafenib—thyroid cancer	0.000148	0.00312	CcSEcCtD
Metformin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000147	0.0031	CcSEcCtD
Metformin—Fatigue—Sorafenib—thyroid cancer	0.000147	0.00309	CcSEcCtD
Metformin—Constipation—Sorafenib—thyroid cancer	0.000146	0.00307	CcSEcCtD
Metformin—NDUFS2—lymph node—thyroid cancer	0.000145	0.00182	CbGeAlD
Metformin—NDUFS3—lymph node—thyroid cancer	0.000143	0.00179	CbGeAlD
Metformin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000139	0.00294	CcSEcCtD
Metformin—Urticaria—Sorafenib—thyroid cancer	0.000135	0.00285	CcSEcCtD
Metformin—Abdominal pain—Sorafenib—thyroid cancer	0.000135	0.00284	CcSEcCtD
Metformin—Renal impairment—Epirubicin—thyroid cancer	0.000134	0.00284	CcSEcCtD
Metformin—Hypoglycaemia—Epirubicin—thyroid cancer	0.000131	0.00277	CcSEcCtD
Metformin—Lethargy—Epirubicin—thyroid cancer	0.000131	0.00275	CcSEcCtD
Metformin—SLC47A1—thyroid gland—thyroid cancer	0.00013	0.00163	CbGeAlD
Metformin—Pain in extremity—Epirubicin—thyroid cancer	0.000128	0.0027	CcSEcCtD
Metformin—Migraine—Epirubicin—thyroid cancer	0.000126	0.00266	CcSEcCtD
Metformin—Renal impairment—Doxorubicin—thyroid cancer	0.000124	0.00262	CcSEcCtD
Metformin—Asthenia—Sorafenib—thyroid cancer	0.000122	0.00258	CcSEcCtD
Metformin—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000121	0.00256	CcSEcCtD
Metformin—Lethargy—Doxorubicin—thyroid cancer	0.000121	0.00255	CcSEcCtD
Metformin—Pruritus—Sorafenib—thyroid cancer	0.00012	0.00254	CcSEcCtD
Metformin—Dehydration—Epirubicin—thyroid cancer	0.000119	0.00251	CcSEcCtD
Metformin—ND1—lymph node—thyroid cancer	0.000119	0.00149	CbGeAlD
Metformin—Pain in extremity—Doxorubicin—thyroid cancer	0.000118	0.0025	CcSEcCtD
Metformin—Liver function test abnormal—Epirubicin—thyroid cancer	0.000118	0.00249	CcSEcCtD
Metformin—Abdominal pain upper—Epirubicin—thyroid cancer	0.000117	0.00246	CcSEcCtD
Metformin—Migraine—Doxorubicin—thyroid cancer	0.000117	0.00246	CcSEcCtD
Metformin—Diarrhoea—Sorafenib—thyroid cancer	0.000116	0.00246	CcSEcCtD
Metformin—Breast disorder—Epirubicin—thyroid cancer	0.000116	0.00244	CcSEcCtD
Metformin—SLC47A1—head—thyroid cancer	0.000115	0.00144	CbGeAlD
Metformin—Nasopharyngitis—Epirubicin—thyroid cancer	0.000114	0.00241	CcSEcCtD
Metformin—Dizziness—Sorafenib—thyroid cancer	0.000113	0.00237	CcSEcCtD
Metformin—Abdominal distension—Epirubicin—thyroid cancer	0.000111	0.00235	CcSEcCtD
Metformin—Influenza—Epirubicin—thyroid cancer	0.000111	0.00233	CcSEcCtD
Metformin—Dehydration—Doxorubicin—thyroid cancer	0.00011	0.00232	CcSEcCtD
Metformin—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000109	0.00231	CcSEcCtD
Metformin—Pancreatitis—Epirubicin—thyroid cancer	0.000108	0.00229	CcSEcCtD
Metformin—Vomiting—Sorafenib—thyroid cancer	0.000108	0.00228	CcSEcCtD
Metformin—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000108	0.00228	CcSEcCtD
Metformin—Angina pectoris—Epirubicin—thyroid cancer	0.000108	0.00227	CcSEcCtD
Metformin—Rash—Sorafenib—thyroid cancer	0.000107	0.00226	CcSEcCtD
Metformin—Dermatitis—Sorafenib—thyroid cancer	0.000107	0.00226	CcSEcCtD
Metformin—Breast disorder—Doxorubicin—thyroid cancer	0.000107	0.00226	CcSEcCtD
Metformin—Headache—Sorafenib—thyroid cancer	0.000107	0.00225	CcSEcCtD
Metformin—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000106	0.00223	CcSEcCtD
Metformin—SLC22A3—thyroid gland—thyroid cancer	0.000104	0.0013	CbGeAlD
Metformin—Neutropenia—Epirubicin—thyroid cancer	0.000103	0.00218	CcSEcCtD
Metformin—Abdominal distension—Doxorubicin—thyroid cancer	0.000103	0.00217	CcSEcCtD
Metformin—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000103	0.00217	CcSEcCtD
Metformin—Influenza—Doxorubicin—thyroid cancer	0.000102	0.00216	CcSEcCtD
Metformin—Nausea—Sorafenib—thyroid cancer	0.000101	0.00213	CcSEcCtD
Metformin—Pancreatitis—Doxorubicin—thyroid cancer	0.0001	0.00212	CcSEcCtD
Metformin—Angina pectoris—Doxorubicin—thyroid cancer	9.97e-05	0.0021	CcSEcCtD
Metformin—Infestation—Epirubicin—thyroid cancer	9.86e-05	0.00208	CcSEcCtD
Metformin—Drowsiness—Epirubicin—thyroid cancer	9.86e-05	0.00208	CcSEcCtD
Metformin—Infestation NOS—Epirubicin—thyroid cancer	9.86e-05	0.00208	CcSEcCtD
Metformin—Neuropathy peripheral—Epirubicin—thyroid cancer	9.67e-05	0.00204	CcSEcCtD
Metformin—SLC22A1—head—thyroid cancer	9.61e-05	0.00121	CbGeAlD
Metformin—Neutropenia—Doxorubicin—thyroid cancer	9.57e-05	0.00202	CcSEcCtD
Metformin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	9.51e-05	0.00201	CcSEcCtD
Metformin—Hepatobiliary disease—Epirubicin—thyroid cancer	9.33e-05	0.00197	CcSEcCtD
Metformin—SLC22A3—head—thyroid cancer	9.19e-05	0.00115	CbGeAlD
Metformin—Infestation NOS—Doxorubicin—thyroid cancer	9.12e-05	0.00192	CcSEcCtD
Metformin—Drowsiness—Doxorubicin—thyroid cancer	9.12e-05	0.00192	CcSEcCtD
Metformin—Infestation—Doxorubicin—thyroid cancer	9.12e-05	0.00192	CcSEcCtD
Metformin—Bradycardia—Epirubicin—thyroid cancer	9.01e-05	0.0019	CcSEcCtD
Metformin—Neuropathy peripheral—Doxorubicin—thyroid cancer	8.94e-05	0.00189	CcSEcCtD
Metformin—Rhinitis—Epirubicin—thyroid cancer	8.87e-05	0.00187	CcSEcCtD
Metformin—Hepatitis—Epirubicin—thyroid cancer	8.85e-05	0.00187	CcSEcCtD
Metformin—Hypoaesthesia—Epirubicin—thyroid cancer	8.81e-05	0.00186	CcSEcCtD
Metformin—Oedema peripheral—Epirubicin—thyroid cancer	8.72e-05	0.00184	CcSEcCtD
Metformin—Connective tissue disorder—Epirubicin—thyroid cancer	8.7e-05	0.00183	CcSEcCtD
Metformin—Hepatobiliary disease—Doxorubicin—thyroid cancer	8.63e-05	0.00182	CcSEcCtD
Metformin—Bradycardia—Doxorubicin—thyroid cancer	8.34e-05	0.00176	CcSEcCtD
Metformin—Eye disorder—Epirubicin—thyroid cancer	8.27e-05	0.00174	CcSEcCtD
Metformin—Flushing—Epirubicin—thyroid cancer	8.22e-05	0.00173	CcSEcCtD
Metformin—Cardiac disorder—Epirubicin—thyroid cancer	8.22e-05	0.00173	CcSEcCtD
Metformin—Rhinitis—Doxorubicin—thyroid cancer	8.21e-05	0.00173	CcSEcCtD
Metformin—Hepatitis—Doxorubicin—thyroid cancer	8.19e-05	0.00173	CcSEcCtD
Metformin—Hypoaesthesia—Doxorubicin—thyroid cancer	8.15e-05	0.00172	CcSEcCtD
Metformin—Oedema peripheral—Doxorubicin—thyroid cancer	8.07e-05	0.0017	CcSEcCtD
Metformin—SLC47A1—lymph node—thyroid cancer	8.07e-05	0.00101	CbGeAlD
Metformin—Connective tissue disorder—Doxorubicin—thyroid cancer	8.05e-05	0.0017	CcSEcCtD
Metformin—Angiopathy—Epirubicin—thyroid cancer	8.03e-05	0.00169	CcSEcCtD
Metformin—Immune system disorder—Epirubicin—thyroid cancer	8e-05	0.00169	CcSEcCtD
Metformin—Mediastinal disorder—Epirubicin—thyroid cancer	7.98e-05	0.00168	CcSEcCtD
Metformin—Chills—Epirubicin—thyroid cancer	7.94e-05	0.00168	CcSEcCtD
Metformin—Erythema—Epirubicin—thyroid cancer	7.71e-05	0.00163	CcSEcCtD
Metformin—Malnutrition—Epirubicin—thyroid cancer	7.71e-05	0.00163	CcSEcCtD
Metformin—Eye disorder—Doxorubicin—thyroid cancer	7.65e-05	0.00161	CcSEcCtD
Metformin—Flushing—Doxorubicin—thyroid cancer	7.6e-05	0.0016	CcSEcCtD
Metformin—Cardiac disorder—Doxorubicin—thyroid cancer	7.6e-05	0.0016	CcSEcCtD
Metformin—Flatulence—Epirubicin—thyroid cancer	7.59e-05	0.0016	CcSEcCtD
Metformin—Dysgeusia—Epirubicin—thyroid cancer	7.55e-05	0.00159	CcSEcCtD
Metformin—Angiopathy—Doxorubicin—thyroid cancer	7.43e-05	0.00157	CcSEcCtD
Metformin—Muscle spasms—Epirubicin—thyroid cancer	7.41e-05	0.00156	CcSEcCtD
Metformin—Immune system disorder—Doxorubicin—thyroid cancer	7.4e-05	0.00156	CcSEcCtD
Metformin—Mediastinal disorder—Doxorubicin—thyroid cancer	7.38e-05	0.00156	CcSEcCtD
Metformin—Chills—Doxorubicin—thyroid cancer	7.35e-05	0.00155	CcSEcCtD
Metformin—Vision blurred—Epirubicin—thyroid cancer	7.26e-05	0.00153	CcSEcCtD
Metformin—Ill-defined disorder—Epirubicin—thyroid cancer	7.15e-05	0.00151	CcSEcCtD
Metformin—Erythema—Doxorubicin—thyroid cancer	7.13e-05	0.0015	CcSEcCtD
Metformin—Malnutrition—Doxorubicin—thyroid cancer	7.13e-05	0.0015	CcSEcCtD
Metformin—Flatulence—Doxorubicin—thyroid cancer	7.03e-05	0.00148	CcSEcCtD
Metformin—Dysgeusia—Doxorubicin—thyroid cancer	6.98e-05	0.00147	CcSEcCtD
Metformin—Malaise—Epirubicin—thyroid cancer	6.95e-05	0.00147	CcSEcCtD
Metformin—Syncope—Epirubicin—thyroid cancer	6.91e-05	0.00146	CcSEcCtD
Metformin—Muscle spasms—Doxorubicin—thyroid cancer	6.86e-05	0.00145	CcSEcCtD
Metformin—Palpitations—Epirubicin—thyroid cancer	6.81e-05	0.00144	CcSEcCtD
Metformin—Loss of consciousness—Epirubicin—thyroid cancer	6.77e-05	0.00143	CcSEcCtD
Metformin—Vision blurred—Doxorubicin—thyroid cancer	6.72e-05	0.00142	CcSEcCtD
Metformin—Hypertension—Epirubicin—thyroid cancer	6.65e-05	0.0014	CcSEcCtD
Metformin—Ill-defined disorder—Doxorubicin—thyroid cancer	6.62e-05	0.0014	CcSEcCtD
Metformin—Chest pain—Epirubicin—thyroid cancer	6.56e-05	0.00138	CcSEcCtD
Metformin—Myalgia—Epirubicin—thyroid cancer	6.56e-05	0.00138	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	6.52e-05	0.00137	CcSEcCtD
Metformin—Discomfort—Epirubicin—thyroid cancer	6.48e-05	0.00137	CcSEcCtD
Metformin—SLC22A3—lymph node—thyroid cancer	6.43e-05	0.000807	CbGeAlD
Metformin—Malaise—Doxorubicin—thyroid cancer	6.43e-05	0.00136	CcSEcCtD
Metformin—Syncope—Doxorubicin—thyroid cancer	6.39e-05	0.00135	CcSEcCtD
Metformin—Palpitations—Doxorubicin—thyroid cancer	6.3e-05	0.00133	CcSEcCtD
Metformin—Oedema—Epirubicin—thyroid cancer	6.29e-05	0.00133	CcSEcCtD
Metformin—Loss of consciousness—Doxorubicin—thyroid cancer	6.27e-05	0.00132	CcSEcCtD
Metformin—Infection—Epirubicin—thyroid cancer	6.25e-05	0.00132	CcSEcCtD
Metformin—Shock—Epirubicin—thyroid cancer	6.19e-05	0.00131	CcSEcCtD
Metformin—Nervous system disorder—Epirubicin—thyroid cancer	6.17e-05	0.0013	CcSEcCtD
Metformin—Thrombocytopenia—Epirubicin—thyroid cancer	6.16e-05	0.0013	CcSEcCtD
Metformin—Hypertension—Doxorubicin—thyroid cancer	6.16e-05	0.0013	CcSEcCtD
Metformin—Skin disorder—Epirubicin—thyroid cancer	6.11e-05	0.00129	CcSEcCtD
Metformin—Hyperhidrosis—Epirubicin—thyroid cancer	6.08e-05	0.00128	CcSEcCtD
Metformin—Chest pain—Doxorubicin—thyroid cancer	6.07e-05	0.00128	CcSEcCtD
Metformin—Myalgia—Doxorubicin—thyroid cancer	6.07e-05	0.00128	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	6.03e-05	0.00127	CcSEcCtD
Metformin—Discomfort—Doxorubicin—thyroid cancer	6e-05	0.00126	CcSEcCtD
Metformin—Anorexia—Epirubicin—thyroid cancer	5.99e-05	0.00126	CcSEcCtD
Metformin—Hypotension—Epirubicin—thyroid cancer	5.88e-05	0.00124	CcSEcCtD
Metformin—Oedema—Doxorubicin—thyroid cancer	5.82e-05	0.00123	CcSEcCtD
Metformin—Infection—Doxorubicin—thyroid cancer	5.78e-05	0.00122	CcSEcCtD
Metformin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	5.73e-05	0.00121	CcSEcCtD
Metformin—Shock—Doxorubicin—thyroid cancer	5.73e-05	0.00121	CcSEcCtD
Metformin—Nervous system disorder—Doxorubicin—thyroid cancer	5.71e-05	0.0012	CcSEcCtD
Metformin—Thrombocytopenia—Doxorubicin—thyroid cancer	5.7e-05	0.0012	CcSEcCtD
Metformin—Skin disorder—Doxorubicin—thyroid cancer	5.65e-05	0.00119	CcSEcCtD
Metformin—Paraesthesia—Epirubicin—thyroid cancer	5.65e-05	0.00119	CcSEcCtD
Metformin—Hyperhidrosis—Doxorubicin—thyroid cancer	5.63e-05	0.00119	CcSEcCtD
Metformin—Dyspnoea—Epirubicin—thyroid cancer	5.61e-05	0.00118	CcSEcCtD
Metformin—Somnolence—Epirubicin—thyroid cancer	5.59e-05	0.00118	CcSEcCtD
Metformin—Anorexia—Doxorubicin—thyroid cancer	5.55e-05	0.00117	CcSEcCtD
Metformin—Dyspepsia—Epirubicin—thyroid cancer	5.54e-05	0.00117	CcSEcCtD
Metformin—Decreased appetite—Epirubicin—thyroid cancer	5.47e-05	0.00115	CcSEcCtD
Metformin—Hypotension—Doxorubicin—thyroid cancer	5.44e-05	0.00115	CcSEcCtD
Metformin—Gastrointestinal disorder—Epirubicin—thyroid cancer	5.43e-05	0.00115	CcSEcCtD
Metformin—Fatigue—Epirubicin—thyroid cancer	5.42e-05	0.00114	CcSEcCtD
Metformin—Constipation—Epirubicin—thyroid cancer	5.38e-05	0.00113	CcSEcCtD
Metformin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	5.3e-05	0.00112	CcSEcCtD
Metformin—Paraesthesia—Doxorubicin—thyroid cancer	5.23e-05	0.0011	CcSEcCtD
Metformin—Dyspnoea—Doxorubicin—thyroid cancer	5.19e-05	0.00109	CcSEcCtD
Metformin—Feeling abnormal—Epirubicin—thyroid cancer	5.18e-05	0.00109	CcSEcCtD
Metformin—Somnolence—Doxorubicin—thyroid cancer	5.17e-05	0.00109	CcSEcCtD
Metformin—Gastrointestinal pain—Epirubicin—thyroid cancer	5.14e-05	0.00108	CcSEcCtD
Metformin—Dyspepsia—Doxorubicin—thyroid cancer	5.12e-05	0.00108	CcSEcCtD
Metformin—Decreased appetite—Doxorubicin—thyroid cancer	5.06e-05	0.00107	CcSEcCtD
Metformin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	5.02e-05	0.00106	CcSEcCtD
Metformin—Fatigue—Doxorubicin—thyroid cancer	5.02e-05	0.00106	CcSEcCtD
Metformin—Urticaria—Epirubicin—thyroid cancer	5e-05	0.00105	CcSEcCtD
Metformin—Constipation—Doxorubicin—thyroid cancer	4.98e-05	0.00105	CcSEcCtD
Metformin—Abdominal pain—Epirubicin—thyroid cancer	4.97e-05	0.00105	CcSEcCtD
Metformin—Feeling abnormal—Doxorubicin—thyroid cancer	4.8e-05	0.00101	CcSEcCtD
Metformin—Gastrointestinal pain—Doxorubicin—thyroid cancer	4.76e-05	0.001	CcSEcCtD
Metformin—Urticaria—Doxorubicin—thyroid cancer	4.62e-05	0.000975	CcSEcCtD
Metformin—Abdominal pain—Doxorubicin—thyroid cancer	4.6e-05	0.00097	CcSEcCtD
Metformin—Asthenia—Epirubicin—thyroid cancer	4.51e-05	0.000952	CcSEcCtD
Metformin—Pruritus—Epirubicin—thyroid cancer	4.45e-05	0.000938	CcSEcCtD
Metformin—Diarrhoea—Epirubicin—thyroid cancer	4.3e-05	0.000908	CcSEcCtD
Metformin—Asthenia—Doxorubicin—thyroid cancer	4.18e-05	0.000881	CcSEcCtD
Metformin—Dizziness—Epirubicin—thyroid cancer	4.16e-05	0.000877	CcSEcCtD
Metformin—Pruritus—Doxorubicin—thyroid cancer	4.12e-05	0.000868	CcSEcCtD
Metformin—Vomiting—Epirubicin—thyroid cancer	4e-05	0.000843	CcSEcCtD
Metformin—Diarrhoea—Doxorubicin—thyroid cancer	3.98e-05	0.00084	CcSEcCtD
Metformin—Rash—Epirubicin—thyroid cancer	3.97e-05	0.000836	CcSEcCtD
Metformin—Dermatitis—Epirubicin—thyroid cancer	3.96e-05	0.000836	CcSEcCtD
Metformin—Headache—Epirubicin—thyroid cancer	3.94e-05	0.000831	CcSEcCtD
Metformin—Dizziness—Doxorubicin—thyroid cancer	3.85e-05	0.000812	CcSEcCtD
Metformin—Nausea—Epirubicin—thyroid cancer	3.74e-05	0.000788	CcSEcCtD
Metformin—Vomiting—Doxorubicin—thyroid cancer	3.7e-05	0.00078	CcSEcCtD
Metformin—Rash—Doxorubicin—thyroid cancer	3.67e-05	0.000774	CcSEcCtD
Metformin—Dermatitis—Doxorubicin—thyroid cancer	3.67e-05	0.000773	CcSEcCtD
Metformin—Headache—Doxorubicin—thyroid cancer	3.65e-05	0.000769	CcSEcCtD
Metformin—Nausea—Doxorubicin—thyroid cancer	3.46e-05	0.000729	CcSEcCtD
Metformin—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	1.25e-05	0.000122	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—ND4—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—ND6—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—ND3—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—ND4L—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—ND2—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—ND5—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—HPGD—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—MINPP1—thyroid cancer	1.15e-05	0.000113	CbGpPWpGaD
Metformin—PRKAB1—Membrane Trafficking—AKT1—thyroid cancer	1.14e-05	0.000112	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TSHR—thyroid cancer	1.12e-05	0.00011	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PRKAR1A—thyroid cancer	1.11e-05	0.000109	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—PTGS2—thyroid cancer	1.1e-05	0.000108	CbGpPWpGaD
Metformin—ND1—Metabolism—SLC5A5—thyroid cancer	1.09e-05	0.000107	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.08e-05	0.000106	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—MINPP1—thyroid cancer	1.07e-05	0.000105	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MEN1—thyroid cancer	1.06e-05	0.000104	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PPARG—thyroid cancer	1.06e-05	0.000104	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PTGS2—thyroid cancer	1e-05	9.83e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PTGS2—thyroid cancer	1e-05	9.83e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PTGS2—thyroid cancer	1e-05	9.83e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PTGS2—thyroid cancer	1e-05	9.83e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NDUFA13—thyroid cancer	9.78e-06	9.59e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTCH1—thyroid cancer	9.56e-06	9.38e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—PTEN—thyroid cancer	9.56e-06	9.38e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PTGS2—thyroid cancer	9.32e-06	9.14e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CHST14—thyroid cancer	9.19e-06	9.02e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—RXRA—thyroid cancer	9.16e-06	8.99e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NDUFA13—thyroid cancer	9.11e-06	8.94e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.11e-06	8.94e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—TPR—thyroid cancer	9.09e-06	8.92e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—CP—thyroid cancer	9.09e-06	8.92e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PPARG—thyroid cancer	8.98e-06	8.81e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PPARG—thyroid cancer	8.98e-06	8.81e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PPARG—thyroid cancer	8.98e-06	8.81e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.94e-06	8.77e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SST—thyroid cancer	8.74e-06	8.58e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PTEN—thyroid cancer	8.74e-06	8.58e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PTEN—thyroid cancer	8.74e-06	8.58e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PTEN—thyroid cancer	8.74e-06	8.58e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PTEN—thyroid cancer	8.74e-06	8.58e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CHST14—thyroid cancer	8.57e-06	8.41e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—BRAF—thyroid cancer	8.53e-06	8.37e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—TPR—thyroid cancer	8.47e-06	8.31e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—CP—thyroid cancer	8.47e-06	8.31e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PPARG—thyroid cancer	8.44e-06	8.28e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CALCA—thyroid cancer	8.41e-06	8.26e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.33e-06	8.18e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTGS2—thyroid cancer	8.3e-06	8.15e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—PTEN—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—BRAF—thyroid cancer	7.95e-06	7.8e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDK1—thyroid cancer	7.62e-06	7.47e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HPGD—thyroid cancer	7.41e-06	7.27e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTEN—thyroid cancer	7.24e-06	7.11e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTGS2—thyroid cancer	7.06e-06	6.93e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTGS2—thyroid cancer	7.06e-06	6.93e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTGS2—thyroid cancer	7.06e-06	6.93e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HPGD—thyroid cancer	6.91e-06	6.78e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.8e-06	6.67e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—TPR—thyroid cancer	6.79e-06	6.66e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PRKAR1A—thyroid cancer	6.68e-06	6.55e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTGS2—thyroid cancer	6.64e-06	6.51e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—BRAF—thyroid cancer	6.54e-06	6.41e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.34e-06	6.22e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTEN—thyroid cancer	6.16e-06	6.04e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTEN—thyroid cancer	6.16e-06	6.04e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTEN—thyroid cancer	6.16e-06	6.04e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NRG1—thyroid cancer	6.11e-06	6e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—BRAF—thyroid cancer	6.09e-06	5.98e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTEN—thyroid cancer	5.79e-06	5.68e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PPARG—thyroid cancer	5.78e-06	5.68e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.71e-06	5.61e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—AKT1—thyroid cancer	5.51e-06	5.4e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TERT—thyroid cancer	5.49e-06	5.39e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.33e-06	5.23e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HIF1A—thyroid cancer	5.25e-06	5.15e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SLC5A5—thyroid cancer	5.08e-06	4.98e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—AKT1—thyroid cancer	5.04e-06	4.94e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—AKT1—thyroid cancer	5.04e-06	4.94e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—AKT1—thyroid cancer	5.04e-06	4.94e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—AKT1—thyroid cancer	5.04e-06	4.94e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—AKT1—thyroid cancer	4.68e-06	4.6e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—thyroid cancer	4.55e-06	4.46e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—BRAF—thyroid cancer	4.35e-06	4.27e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—RXRA—thyroid cancer	4.27e-06	4.19e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TPR—thyroid cancer	4.26e-06	4.18e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PRKAR1A—thyroid cancer	4.19e-06	4.11e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—AKT1—thyroid cancer	4.17e-06	4.1e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTEN—thyroid cancer	3.97e-06	3.89e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TPR—thyroid cancer	3.97e-06	3.89e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	3.92e-06	3.85e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PRKAR1A—thyroid cancer	3.9e-06	3.83e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—HRAS—thyroid cancer	3.66e-06	3.59e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—AKT1—thyroid cancer	3.55e-06	3.48e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—AKT1—thyroid cancer	3.55e-06	3.48e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—AKT1—thyroid cancer	3.55e-06	3.48e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—AKT1—thyroid cancer	3.34e-06	3.27e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC5A5—thyroid cancer	3.19e-06	3.13e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCND1—thyroid cancer	3.17e-06	3.11e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTEN—thyroid cancer	3.06e-06	3e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—HRAS—thyroid cancer	3.01e-06	2.95e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC5A5—thyroid cancer	2.97e-06	2.91e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—HRAS—thyroid cancer	2.8e-06	2.75e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NRAS—thyroid cancer	2.73e-06	2.68e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PPARG—thyroid cancer	2.69e-06	2.64e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—RXRA—thyroid cancer	2.68e-06	2.63e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—RXRA—thyroid cancer	2.49e-06	2.45e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KRAS—thyroid cancer	2.35e-06	2.31e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—AKT1—thyroid cancer	2.29e-06	2.24e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—thyroid cancer	2.12e-06	2.08e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—thyroid cancer	2.09e-06	2.05e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HRAS—thyroid cancer	2e-06	1.96e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTEN—thyroid cancer	1.85e-06	1.81e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT1—thyroid cancer	1.76e-06	1.73e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPARG—thyroid cancer	1.69e-06	1.66e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPARG—thyroid cancer	1.58e-06	1.55e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—thyroid cancer	1.33e-06	1.3e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—thyroid cancer	1.24e-06	1.22e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTEN—thyroid cancer	1.16e-06	1.14e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTEN—thyroid cancer	1.08e-06	1.06e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKT1—thyroid cancer	1.07e-06	1.05e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKT1—thyroid cancer	6.68e-07	6.56e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKT1—thyroid cancer	6.23e-07	6.11e-06	CbGpPWpGaD
